A NEW approach to treatment of hypertension in the form of a triple ingredient medication has proved to be very successful at bringing hypertensive patients to target levels of 140/90 mm Hg or less.
The study enrolled 700 Sri Lankan patients with an average age of 56 and blood pressure of 154/90 mm Hg, randomised to either standard of care or the new combination product of telmisartan (20 mg), amlodipine (2.5 mg), and chlorthalidone (12.5 mg), each of the elements being at half dose.
Statistical significance was achieved and may impact on guideline revisions, authors said.
CLICK HERE for the research.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Aug 18
